Literature DB >> 22025617

Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.

Paulus H S Kwakman1, Jeroen Krijgsveld, Leonie de Boer, Leonard T Nguyen, Laura Boszhard, Jocelyne Vreede, Henk L Dekker, Dave Speijer, Jan W Drijfhout, Anje A te Velde, Wim Crielaard, Hans J Vogel, Christina M J E Vandenbroucke-Grauls, Sebastian A J Zaat.   

Abstract

Chemokines (chemotactic cytokines) can have direct antimicrobial activity, which is apparently related to the presence of a distinct positively charged patch on the surface. However, chemokines can retain antimicrobial activity upon linearization despite the loss of their positive patch, thus questioning the importance of this patch for activity. Thrombocidin-1 (TC-1) is a microbicidal protein isolated from human blood platelets. TC-1 only differs from the chemokine NAP-2/CXCL7 by a two-amino acid C-terminal deletion, but this truncation is crucial for antimicrobial activity. We assessed the structure-activity relationship for antimicrobial activity of TC-1. Reduction of the charge of the TC-1-positive patch by replacing lysine 17 with alanine reduced the activity against bacteria and almost abolished activity against the yeast Candida albicans. Conversely, augmentation of the positive patch by increasing charge density or size resulted in a 2-3-fold increased activity against Staphylococcus aureus, Escherichia coli, and Bacillus subtilis but did not substantially affect activity against C. albicans. Reduction of TC-1 resulted in loss of the folded conformation, but this disruption of the positive patch did not affect antimicrobial activity. Using overlapping 15-mer synthetic peptides, we demonstrate peptides corresponding to the N-terminal part of TC-1 to have similar antimicrobial activity as intact TC-1. Although we demonstrate that the positive patch is essential for activity of folded TC-1, unfolded TC-1 retained antimicrobial activity despite the absence of a positive patch. This activity is probably exerted by a linear peptide stretch in the N-terminal part of the molecule. We conclude that intact TC-1 and unfolded TC-1 exert antimicrobial activity via distinct structural elements.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025617      PMCID: PMC3234844          DOI: 10.1074/jbc.M111.248641

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Diversity of antimicrobial peptides and their mechanisms of action.

Authors:  R M Epand; H J Vogel
Journal:  Biochim Biophys Acta       Date:  1999-12-15

Review 2.  Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes.

Authors:  K Matsuzaki
Journal:  Biochim Biophys Acta       Date:  1999-12-15

3.  Action of antimicrobial peptides: two-state model.

Authors:  H W Huang
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

4.  Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity.

Authors:  A M Cole; T Ganz; A M Liese; M D Burdick; L Liu; R M Strieter
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

Review 5.  The expanding scope of antimicrobial peptide structures and their modes of action.

Authors:  Leonard T Nguyen; Evan F Haney; Hans J Vogel
Journal:  Trends Biotechnol       Date:  2011-06-15       Impact factor: 19.536

6.  Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.

Authors:  J Krijgsveld; S A Zaat; J Meeldijk; P A van Veelen; G Fang; B Poolman; E Brandt; J E Ehlert; A J Kuijpers; G H Engbers; J Feijen; J Dankert
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

7.  NMR solution structure of murine CCL20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6.

Authors:  J M Pérez-Cañadillas; A Zaballos; J Gutiérrez; R Varona; F Roncal; J P Albar; G Márquez; M Bruix
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

8.  Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis.

Authors:  J Dankert; J Krijgsveld; J van Der Werff; W Joldersma; S A Zaat
Journal:  J Infect Dis       Date:  2001-07-31       Impact factor: 5.226

9.  Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.

Authors:  S Kobayashi; K Takeshima; C B Park; S C Kim; K Matsuzaki
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

10.  Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue.

Authors:  Karthik Balakrishna Chandrababu; Bow Ho; Daiwen Yang
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

View more
  9 in total

1.  Role of platelets in immune system and inflammation.

Authors:  Ozge Sonmez; Mehmet Sonmez
Journal:  Porto Biomed J       Date:  2017-10-12

Review 2.  Platelets and Their Interactions with Other Immune Cells.

Authors:  Fong W Lam; K Vinod Vijayan; Rolando E Rumbaut
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 3.  Challenges and innovations in treating chronic and acute wound infections: from basic science to clinical practice.

Authors:  Xiaotong Ding; Qinghan Tang; Zeyu Xu; Ye Xu; Hao Zhang; Dongfeng Zheng; Shuqin Wang; Qian Tan; Joanneke Maitz; Peter K Maitz; Shaoping Yin; Yiwei Wang; Jun Chen
Journal:  Burns Trauma       Date:  2022-05-21

Review 4.  Bacterial Evasion of Host Antimicrobial Peptide Defenses.

Authors:  Jason N Cole; Victor Nizet
Journal:  Microbiol Spectr       Date:  2016-02

5.  Structural perspectives on antimicrobial chemokines.

Authors:  Leonard T Nguyen; Hans J Vogel
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

Review 6.  Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.

Authors:  Julio Valdivia-Silva; Jaciel Medina-Tamayo; Eduardo A Garcia-Zepeda
Journal:  Int J Mol Sci       Date:  2015-06-08       Impact factor: 5.923

Review 7.  Antimicrobial Peptides in Biomedical Device Manufacturing.

Authors:  Martijn Riool; Anna de Breij; Jan W Drijfhout; Peter H Nibbering; Sebastian A J Zaat
Journal:  Front Chem       Date:  2017-08-24       Impact factor: 5.221

Review 8.  Multitarget Approaches against Multiresistant Superbugs.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084

Review 9.  The Platelet Response to Tissue Injury.

Authors:  Felix Eisinger; Johannes Patzelt; Harald F Langer
Journal:  Front Med (Lausanne)       Date:  2018-11-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.